Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DA-21-016

Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)

Closed on February 26, 2021.

Posted
December 23, 2020
Close date
February 26, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $220,098 in first-year total cost, median $220,098.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 TXT-V (04)]1

Most frequent institutions

  1. C4 INNOVATIONS, LLC1
Competing awards under RFA-DA-21-016 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Overcoming Stigma and Improving Outcomes for Substance Use Disorders Through Education, Engagement, and Empowerment1R43DA055182-01EDENS, ELLEN LMARCOGLIESE, BETHANYC4 INNOVATIONS, LLC, MA$220,098ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works